Company intelligence / Profile preview

Biotron Diagnostics

Hemet, California, United Statesbiotrondiagnostics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Over three decades of commercial success with FDA-approved in vitro diagnostic kits and reagents distributed worldwide. No clinical trial pipeline as typical for therapeutics companies—focus is on regulatory-cleared commercial products.

Therapeutic areas: OncologyInfectious DiseasesEndocrinologyOtherCardiovascularWomen's Health
Modalities: Diagnostic reagents and kitsELISA/CLIA-based immunoassaysMolecular diagnostics (gene testing assays)Rapid diagnostic testsClinical chemistry reagents
Industry: Molecular Diagnostics

Partnerships

OEM/private label partnerships with other healthcare companies; specifics not disclosed publicly.

Beyond the preview

Go deeper on Biotron Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotron Diagnostics.

Explore the full profile